MYUNGMOON PharmLtd Balance Sheet Health
Financial Health criteria checks 4/6
MYUNGMOON PharmLtd has a total shareholder equity of ₩85.7B and total debt of ₩92.2B, which brings its debt-to-equity ratio to 107.7%. Its total assets and total liabilities are ₩239.6B and ₩153.9B respectively.
Key information
107.7%
Debt to equity ratio
₩92.22b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩11.77b |
| Equity | ₩85.65b |
| Total liabilities | ₩153.95b |
| Total assets | ₩239.60b |
Recent financial health updates
Is MYUNGMOON PharmLtd (KRX:017180) Weighed On By Its Debt Load?
Sep 06
MYUNGMOON PharmLtd (KRX:017180) Has No Shortage Of Debt
Mar 21Does MYUNGMOON PharmLtd (KRX:017180) Have A Healthy Balance Sheet?
Mar 31Does Myungmoon Pharm (KRX:017180) Have A Healthy Balance Sheet?
Dec 15
Recent updates
Is MYUNGMOON PharmLtd (KRX:017180) Weighed On By Its Debt Load?
Sep 06MYUNGMOON Pharm co.,Ltd's (KRX:017180) 35% Share Price Surge Not Quite Adding Up
Jul 26MYUNGMOON PharmLtd (KRX:017180) Has No Shortage Of Debt
Mar 21Does MYUNGMOON PharmLtd (KRX:017180) Have A Healthy Balance Sheet?
Mar 31Introducing MYUNGMOON PharmLtd (KRX:017180), A Stock That Climbed 77% In The Last Five Years
Feb 06Does Myungmoon Pharm (KRX:017180) Have A Healthy Balance Sheet?
Dec 15Financial Position Analysis
Short Term Liabilities: A017180's short term assets (₩84.3B) do not cover its short term liabilities (₩90.6B).
Long Term Liabilities: A017180's short term assets (₩84.3B) exceed its long term liabilities (₩63.3B).
Debt to Equity History and Analysis
Debt Level: A017180's net debt to equity ratio (93.9%) is considered high.
Reducing Debt: A017180's debt to equity ratio has reduced from 127.8% to 107.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A017180 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A017180 has sufficient cash runway for 1.3 years if free cash flow continues to grow at historical rates of 14.7% each year.